definition points of highlighted subtitles
TRANSCRIPT
![Page 1: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/1.jpg)
• Definition • Points of highlighted subtitles
![Page 2: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/2.jpg)
International classifications of diseases ICD-11 group #18 Pregnancy, childbirth or the puerperium
• Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium
• Obstetric haemorrhage
diabetes
![Page 3: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/3.jpg)
• Gestational diabetes
• Preeclampsia
• Haemorrhagic complications
![Page 4: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/4.jpg)
• Definition of gestational diabetes • Any degree of glucose intolerancewith onset of first recognitionduring pregnancy
• Fasting serum glucose >7,1 mmol/L• Random plasma glucose >11,1
mmol/L• The definition applies whether
insulin or only diet modification is used for treatment and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy.
![Page 5: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/5.jpg)
• Definition of gestational diabetes
• Incidence• 7% of all pregnancies
• Prevalence varies between 1-14%
• Common complications
Fetal macrosomia
Urinary tract infection
Preterm delivery
Preeclampsia
Delayed lung maturation, IRDS
Neonatal jaundice, polycytaemia, hypocalcaemia, seizures
Perinatal death
Long-term CVD consequences in mother and offspring
![Page 6: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/6.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Multiparity
• Advanced age
• Family history of diabetes
• Previous GDM
• High prepregnancy BMI
• Autoimmune diseases
• Smoking
• American African/Hispanic/Asianethnicity
• Sedentary lifestyle
![Page 7: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/7.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Pathophysiology • β-cell dysfunction
• Insulin independent placental glucose-transport
• Suppressed insulin-receptor signalling
• ↑ Leptin level
• ↓ Adiponectin level
![Page 8: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/8.jpg)
Plows et al. Int. J. Mol. Sci. 2018, 19, 3342; doi:10.3390/ijms19113342
![Page 9: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/9.jpg)
Plows et al. Int. J. Mol. Sci. 2018, 19, 3342; doi:10.3390/ijms19113342
![Page 10: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/10.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Failed conception (↑ HbA1c)
• Cardiovascular malformation
• Hyperglycaemia
• Glycosuria
• Recurrent UTI
• Polyhydramnion
• Subcutaneous fat layer
• Macrosomia
• PIH
• PET
![Page 11: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/11.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Fetal growth
![Page 12: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/12.jpg)
![Page 13: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/13.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Plows et al. Int. J. Mol. Sci. 2018, 19, 3342; doi:10.3390/ijms19113342
![Page 14: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/14.jpg)
Plows et al. Int. J. Mol. Sci. 2018, 19, 3342; doi:10.3390/ijms19113342
![Page 15: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/15.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Biochemical markers: Se-glucose, fructosamine, HBA1c, OGTT
• Fetoplacental markers: growth(AC), amniotic fluid volume, subcutaneous fat, functionaltests
• Assessment of diet, physicalactivity
• Regular BP-check, urinanalysis
![Page 16: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/16.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Treatment
• Nutritional counseling
• Calorie restriction to 25 kcal/kg/day
• Carbohydrates restriction to 180 g/day
• Bodyweight monitoring
• Moderate excercise
• Insulin therapy if 2h postprandial plasma-glucose >7,2 mmol/L
• Avoid prolonged pregnancy
• Breastfeeding
![Page 17: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/17.jpg)
• Definition of gestational diabetes
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Screening and prevention
• Obstetric/Medical/Family history
• Prepregnancy check on glucose-metabolism
• Regular BP and urine-analysis
• Dietary advice
• Prepregnancy BMI normalisation
![Page 18: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/18.jpg)
• Definition of preeclampsia
• BP>140/90 twice at resting 4 hours apart
• >0.5 g/L or >+ proteinuria in theabsence of UTI (pyuria)
• Develops after 20th week and normalized within 3 monthsafter delivery
• Carries high morbidity asopposed to Pregnancy InducedHypertension
![Page 19: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/19.jpg)
• Definition of preeclampsia
• Incidence• 4-7% overall
• 75% occurs near term
• Complications
DIC/HELLP 10-20%
ARDS 2-5%
Abruption 1-5%
Eclampsia 1%
Renal failure 1%
Preterm delivery 15-60%
IUGR 10-25%
Perinatal death 1-2%
![Page 20: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/20.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Primiparity
• Extremes of age
• Previous PET
• Primipaternity
• Limited sperm exposure
• Donor sperm or oocyte
• Chronic hypertension
• Diabetes
• Autoimmune diseases
• Smoking
• Family history of PET
![Page 21: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/21.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Pathophysiology, Placentation
![Page 22: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/22.jpg)
![Page 23: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/23.jpg)
![Page 24: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/24.jpg)
![Page 25: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/25.jpg)
![Page 26: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/26.jpg)
![Page 27: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/27.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Uterine artery notch
• ↑ β-hCG
• Increased weight-gain
• Oedema, ↑Htc, „normal” Hb
• Failed midtrimester ↓BP
• ↑BP, proteinuria
• Hyperreflexia, clonus, eclamptic fit
Frontal headache,
Epigastric pain,
Visual disturbances
![Page 28: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/28.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Fetal growth restriction
![Page 29: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/29.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Fetal growth restriction
• Placental abruption
![Page 30: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/30.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• BP>140/90 twice at resting 4 hours apart
• >0.5 g/L or >+ proteinuria inthe absence of UTI (pyuria)
Frontal headache,
Epigastric pain,
Visual disturbances
![Page 31: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/31.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Physical markers: Wt, BP
• Haematological markers: Hb, Htc, Plt, APTT, INR, FDP, D-dimer
• Biochemical markers: Proteinuria, Se-uric acid, Urine Ca/Crea, GOT, Se-Alb, Urine output
• Fetoplacental markers
![Page 32: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/32.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Treatment
• No fluid restriction
• Protein supplementation (p.o., i.v.)
• Antihypertensive TxAntidopaminerg
Ca-channel blockers
α-β-blockers
• Hospitalisation, bedrest
• Volumen expansion (iv.Albumin/HAES)
• Antihypertensive Tx (Urapidil,Hydralazin)
• Anticonvulsant Tx (MgSO4)
![Page 33: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/33.jpg)
• Definition of preeclampsia
• Incidence
• Risk factors
• Presentation, signs and symptoms
• Diagnosis
• Special investigations
• Screening and prevention
• Obstetric/Medical/Family history
• First trimester biochemical screening
• First trimester uterine artery doppler
• Baseline biochemistry
• Regular BP and urine-analysis
• Dietary advice
• Ca-supplementation
• Vitamins C and E
• Fish-oil
• Aspirin
![Page 34: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/34.jpg)
• Definitions
Revealed or concealed bleedingafter 20 weeks
Loss of >500mL from the genitaltract within 24 hrs (primary PPH)
Or within 3mths (secondary PPH)
![Page 35: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/35.jpg)
• Epidemiology
• 2-3% frequency
• Increasing
• 3rd most common cause of maternal mortality
• Increases with parity
• Increases with age
• Increases with CS frequency
![Page 36: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/36.jpg)
• Causes
• Abruption
• Placenta praevia
• Vasa praevia
• Trauma of birth-canal
• Atony
• Abnormal placentation
• Inversion
• Cervical cancer
• Haemostatic disorders
![Page 37: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/37.jpg)
• Classification
• Abruption
Revealed and concealed
• Placenta praevia
Low lying, marginal and central
• Adherent placenta
Placenta accreta, increta and percreta
• Haemostatic disorders
Coagulopathy, thrombocytopathy, vasculopathyInherited, acquired
General, gender-specific
![Page 38: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/38.jpg)
![Page 39: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/39.jpg)
![Page 40: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/40.jpg)
![Page 41: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/41.jpg)
![Page 42: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/42.jpg)
• Diagnosis
• Quick check of four Ts(Tone,Tissue,Trauma,Thrombin)
• Amount of lost blood
• Physical properties of lost blood
• Previous episodes of bleeding
• Uterine tone and irritability
• Painful or painless
• Relation between loss and general state
• Precipitating factor
• Clotting screen
![Page 43: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/43.jpg)
• Treatment
• Summon help at most senior level• O2 mask• 2x14-gauge iv.lines• FBC+clotting screen• X-match 6 units (massive haemorrhage)• Fluid (christalloid) resuscitation with CVP control• Foley catheter insertion for diuresis monitoring• Transfuse ASAP (O Rh.neg. if at hand)• FFP, Cryoprecipitate, Platelet• Eliminate cause
![Page 44: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/44.jpg)
• Prevention
• Early US, regular US-follow-up• Detailed history taking to identify risk factors• Folic acid and Iron supplementation• Continuous risk assessment• Careful antenatal follow-up• Prophylactic measures (smoking and drug-
use cessation, avoid prolonged labour, X-match, large bore iv.line, avoidhyperstimulation, atony prevention, activemanagement of 3rd stage, careful check forretained placental tissues, haematologicalconsultation)
![Page 45: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/45.jpg)
F1-level and the risk of major obstetrichaemorrhage
• Initial F1 > 4 g/L had a negative predictive value of 80% for PPH
• Initial F1 < 2 g/L had a positive predictive value of 100% for PPH
![Page 46: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/46.jpg)
Further retrospective data
![Page 47: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/47.jpg)
Hungarian F1 reference data
![Page 48: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/48.jpg)
0
10
20
30
40
50
60
70
80
90
0,00 1,00 2,00 3,00 4,00 5,00 6,00 7,00 8,00 9,00 10,00
Ese
tszá
m (
N)
Fibrinogén-szint (g/L)
FREQUENCY DISTRIBUTION OF FIBRINOGEN-LEVELS
![Page 49: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/49.jpg)
0
1
2
3
4
5
6
7
8
9
10
10 15 20 25 30 35 40
Fib
rin
og
en
g/L
Weeks
Fibrinogen-level as a function of gestational age
![Page 50: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/50.jpg)
0
5
10
15
20
25
30
35
40
45
50
3 3,5 4 4,5 5 5,5 6 6,5 7 7,5 8
Da
ys
tod
eliv
ery
Fibrinogen-level (g/L)
Dot-plot of days to delivery and fibrinogen levels
![Page 51: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/51.jpg)
2013.11.22
2014.01.11
2014.03.02
2014.04.21
2014.06.10
2014.07.30
2014.09.18
2014.11.07
0 1 2 3 4 5 6 7 8 9 10
Da
te
Fibrinogen-level (g/L)
Dot-plot of fibrinogen-levels by date
![Page 52: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/52.jpg)
0
50
100
150
200
250
300
0 5 10 15 20 25 30 35 40 45
N
Weeks
FREQUENCY DISTRIBUTION OF GESTATIONAL AGE
![Page 53: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/53.jpg)
0
10
20
30
40
0 1 2 3 4 5 6 7 8 9 10N
Fibrinogen (g/L)
Frequency distribution of fibrinogen-levels onBCS automate in 2014
0
20
40
60
80
0 1 2 3 4 5 6 7 8 9 10
N
Fibrinogen (g/L)
Frequency distribution of fibrinogen-levels onBCSXP automate in 2014
![Page 54: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/54.jpg)
0
10
20
30
40
50
60
0 1 2 3 4 5 6 7 8 9 10
BCS2 results in 2013
0
10
20
30
40
50
60
70
80
0 1 2 3 4 5 6 7 8 9 10
BCSXP2 results 2013
![Page 55: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/55.jpg)
3,51-7,38 g/L 3,43-4,96 g/L
0
50
100
150
200
250
0 1 2 3 4 5 6 7 8 9 10
N
Fibrinogen (g/L)
Pregnant F1-level distribution in 2013-2014, N=2072)
![Page 56: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/56.jpg)
Dilution experiment with a sample of10 g/L fibrinogen level
R² = 0,9664
0
2
4
6
8
10
12
0 1 2 3 4 5 6 7
Fib
rin
og
en
-le
vel(
g/L
)
Dilution
![Page 57: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/57.jpg)
The occurrence of hemorrhagic obstetric complication, transfusion, and low fibrinogen
level between 2009 and 2013
68
150
109
37 34
58 59
45 44
67
47
18
62
37
15 6 13 10 5 6 13 185 11 13 5 1 0 0 0 0 0 0
2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Major haemorrhage Transfusion Low F1
![Page 58: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/58.jpg)
Statistical obstetric indicators of cases above and under 5 g/L fibrinogen level
F1≥5 G/L F1<5 G/L STATISTICAL
ASSESSMENT
CASE NUMBER 509 1563MEAN AGE 30,84 years 30,75 years p=0,704MEAN GRAVIDITY 1,85 2,03 p=0,01
MEAN PARITY 1,46 1,63 p=0,00002MEAN BIRTHWEIGHT 3365 g 3393 g p=0,29
PREMATURE BIRTH
FREQUENCY23/509 65/1563 OR=1,09 (0,67-1,77)
CAESAREAN SECTION 200/509 548/1563 OR=1,2 (0,97-1,47)
GESTATIONAL DIABETES 18/509 35/1563 OR=1,6 (0,9-2,9)
PREECLAMPSIA 50/509 77/1563 OR=2,1 (1,45-3,05)
![Page 59: Definition Points of highlighted subtitles](https://reader030.vdocuments.site/reader030/viewer/2022012719/61b24e66b269a75c624dbb2e/html5/thumbnails/59.jpg)
Risk reduction of major obstetric haemorrhage
• Definitions
• Causes
• Treatment• Prevention
• Early scan, regular US check
• Detailed history and risk assessment
• Folic acid and iron supplementation
• Continuing risk assessment
• Prophylactic measures (stop smoking and drug use, avoid prolonged labour, avoid hyperstimulation, G&S, Xmatch RBC, large-bore iv.cannula, prevention of atony, active management of 3rd stage, careful checkof placenta, involve haematologist)
• F1 screening• F1 stock• Preemptive F1-supplementation